Literature DB >> 21343310

Sequence-independent control of peptide conformation in liposomal vaccines for targeting protein misfolding diseases.

David T Hickman1, María Pilar López-Deber, Dorin Mlaki Ndao, Alberto B Silva, Deepak Nand, Maria Pihlgren, Valérie Giriens, Rime Madani, Annie St-Pierre, Hristina Karastaneva, Luitgard Nagel-Steger, Dieter Willbold, Detlev Riesner, Claude Nicolau, Marc Baldus, Andrea Pfeifer, Andreas Muhs.   

Abstract

Synthetic peptide immunogens that mimic the conformation of a target epitope of pathological relevance offer the possibility to precisely control the immune response specificity. Here, we performed conformational analyses using a panel of peptides in order to investigate the key parameters controlling their conformation upon integration into liposomal bilayers. These revealed that the peptide lipidation pattern, the lipid anchor chain length, and the liposome surface charge all significantly alter peptide conformation. Peptide aggregation could also be modulated post-liposome assembly by the addition of distinct small molecule β-sheet breakers. Immunization of both mice and monkeys with a model liposomal vaccine containing β-sheet aggregated lipopeptide (Palm1-15) induced polyclonal IgG antibodies that specifically recognized β-sheet multimers over monomer or non-pathological native protein. The rational design of liposome-bound peptide immunogens with defined conformation opens up the possibility to generate vaccines against a range of protein misfolding diseases, such as Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21343310      PMCID: PMC3077597          DOI: 10.1074/jbc.M110.186338

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization.

Authors:  J-M Orgogozo; S Gilman; J-F Dartigues; B Laurent; M Puel; L C Kirby; P Jouanny; B Dubois; L Eisner; S Flitman; B F Michel; M Boada; A Frank; C Hock
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

2.  Non-covalent stabilization of a beta-hairpin peptide into liposomes.

Authors:  Dennis W P M Löwik; Jeffrey G Linhardt; P J Hans M Adams; Jan C M van Hest
Journal:  Org Biomol Chem       Date:  2003-06-07       Impact factor: 3.876

3.  Effects of immunization with CCR5-based cycloimmunogen on simian/HIVSF162P3 challenge.

Authors:  Shogo Misumi; Daisuke Nakayama; Masashi Kusaba; Takaaki Iiboshi; Ryouzaburo Mukai; Kuniomi Tachibana; Tadashi Nakasone; Mamoru Umeda; Hideaki Shibata; Masafumi Endo; Nobutoki Takamune; Shozo Shoji
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

4.  Mechanism of thioflavin T binding to amyloid fibrils.

Authors:  Ritu Khurana; Chris Coleman; Cristian Ionescu-Zanetti; Sue A Carter; Vinay Krishna; Rajesh K Grover; Raja Roy; Shashi Singh
Journal:  J Struct Biol       Date:  2005-09       Impact factor: 2.867

5.  Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Takeshi Kawarabayashi; Mikio Shoji; Linda H Younkin; Lin Wen-Lang; Dennis W Dickson; Tetsuro Murakami; Etsuro Matsubara; Koji Abe; Karen Hsiao Ashe; Steven G Younkin
Journal:  J Neurosci       Date:  2004-04-14       Impact factor: 6.167

6.  Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.

Authors:  H LeVine
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

7.  Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes.

Authors:  Suman Jha; Daniel Sellin; Ralf Seidel; Roland Winter
Journal:  J Mol Biol       Date:  2009-05-07       Impact factor: 5.469

8.  Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice.

Authors:  Andreas Muhs; David T Hickman; Maria Pihlgren; Nathalie Chuard; Valérie Giriens; Carine Meerschman; Ingrid van der Auwera; Fred van Leuven; Masae Sugawara; Marie-Catherine Weingertner; Burkhard Bechinger; Ruth Greferath; Nadine Kolonko; Luitgard Nagel-Steger; Detlev Riesner; Roscoe O Brady; Andrea Pfeifer; Claude Nicolau
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-21       Impact factor: 11.205

9.  Copper(II) binding to amyloid-beta fibrils of Alzheimer's disease reveals a picomolar affinity: stoichiometry and coordination geometry are independent of Abeta oligomeric form.

Authors:  Claire J Sarell; Christopher D Syme; Stephen E J Rigby; John H Viles
Journal:  Biochemistry       Date:  2009-05-26       Impact factor: 3.162

10.  Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine.

Authors:  Tais A P F Pimentel; Zhe Yan; Scott A Jeffers; Kathryn V Holmes; Robert S Hodges; Peter Burkhard
Journal:  Chem Biol Drug Des       Date:  2009-01       Impact factor: 2.817

View more
  31 in total

1.  Supramolecular structure of membrane-associated polypeptides by combining solid-state NMR and molecular dynamics simulations.

Authors:  Markus Weingarth; Christian Ader; Adrien S J Melquiond; Deepak Nand; Olaf Pongs; Stefan Becker; Alexandre M J J Bonvin; Marc Baldus
Journal:  Biophys J       Date:  2012-07-03       Impact factor: 4.033

2.  Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.

Authors:  Gary R Matyas; Alexander V Mayorov; Kenner C Rice; Arthur E Jacobson; Kejun Cheng; Malliga R Iyer; Fuying Li; Zoltan Beck; Kim D Janda; Carl R Alving
Journal:  Vaccine       Date:  2013-04-23       Impact factor: 3.641

Review 3.  Improving Memory and Cognition in Individuals with Down Syndrome.

Authors:  Michael S Rafii
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

Review 4.  Immunotherapeutic approaches for Alzheimer's disease.

Authors:  Thomas Wisniewski; Fernando Goñi
Journal:  Neuron       Date:  2015-03-18       Impact factor: 17.173

5.  Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex.

Authors:  Zoltan Beck; Oscar B Torres; Gary R Matyas; David E Lanar; Carl R Alving
Journal:  J Control Release       Date:  2018-02-09       Impact factor: 9.776

6.  "Tau immunotherapy: Hopes and hindrances".

Authors:  Koorosh Shahpasand; Alireza Sepehri Shamloo; Seyed Massood Nabavi; Kun Ping Lu; Xiao Zhen Zhou
Journal:  Hum Vaccin Immunother       Date:  2017-12-01       Impact factor: 3.452

7.  Novel immunological approaches for the treatment of Alzheimer's disease.

Authors:  Priyanka Sabharwal; Thomas Wisniewski
Journal:  Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi       Date:  2014

Review 8.  Immunogenicity of DNA- and recombinant protein-based Alzheimer disease epitope vaccines.

Authors:  Hayk Davtyan; Andrew Bacon; Irina Petrushina; Karen Zagorski; David H Cribbs; Anahit Ghochikyan; Michael G Agadjanyan
Journal:  Hum Vaccin Immunother       Date:  2014-02-13       Impact factor: 3.452

Review 9.  Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.

Authors:  Elvira Valera; Brian Spencer; Eliezer Masliah
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 10.  Developing therapeutic vaccines against Alzheimer's disease.

Authors:  Thomas Wisniewski; Eleanor Drummond
Journal:  Expert Rev Vaccines       Date:  2015-12-11       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.